When evaluating a novel viral-vector-based gene therapy, accurately determining dose and potency is essential for patient safety. ATCC supports this need by providing internationally accepted viral reference materials that enable the standardization of quantification techniques between organizations.

Our high-performance media are expertly designed to support the recovery, expansion, cryopreservation, and distribution of ATCC cell lines, virtually guaranteeing successful cell culture every time you thaw a frozen vial of cells.

ATCC has developed titered mycoplasma reference standards for comparing PCR and culture-based detection methods, and quantitative mycoplasma DNA certified reference materials for use as external controls in inclusivity/exclusivity testing and establishing limits of detection.

Discover how HepatoXcell™ can support your predictive drug development and toxicity testing.

ATCC PBMCs are cryopreserved, ethically sourced immune cells with high viability, ideal for reliable immunology research and functional assays.

Learn about our precisely quantitated microbial reference materials for streamlining microbial quality control testing.

The ATCC Genome Portal is a rapidly growing ISO 9001–compliant database of whole-exome and RNA-seq datasets from authenticated cell lines in the ATCC collection.

ATCC used cutting-edge CRISPR/Cas9 gene-editing technology to develop STAT1 knockout or STAT1/BAX double knockout cell lines capable of producing high-titer viral stocks. Discover how these advanced biological models can be used in your vaccine and gene therapeutic development projects.